AKOYA BIOSCIENCES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.8 USD | -0.52% |
|
0.00% | -22.13% |
Chart calendar Akoya Biosciences, Inc.
44cd9b.ZWTC908XKio7gUYSDs7a4VdPuwZAgzmMNOe4kA3jqIo.Vh24kHovRBwM8DZZUYiQjgcp7Wl5sAm4B5bvwEqx6t9dAYuOJFNkZhb3dg~8e1300615f3ce90366e9b9cbe41f2290
Upcoming events on Akoya Biosciences, Inc.
Past events on Akoya Biosciences, Inc.
| 2024-03-04 05:00 pm | Q4 2023 Earnings Call |
| 2024-03-04 04:05 pm | Q4 2023 Earnings Release |
| 2024-02-12 | BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference |
| 2024-01-10 06:45 pm | JPMorgan Healthcare Conference |
| 2024-01-07 08:00 am | Q1 2023 Sales and Revenue Release |
| 2023-11-30 11:30 am | Piper Sandler Healthcare Conference |
| 2023-11-16 02:30 pm | Canaccord Genuity MedTech Diagnostics and Digital Health and Services Forum |
| 2023-11-15 12:00 pm | Stephens Investment Conference |
| 2023-11-08 05:00 pm | Q3 2023 Earnings Call |
| 2023-11-08 04:00 pm | Q3 2023 Earnings Release |
| 2023-11-04 12:00 pm | Society for Immunotherapy of Cancer Meeting - Poster Number 570 |
| 2023-11-04 12:00 pm | Society for Immunotherapy of Cancer Meeting - Poster Number 90 |
| 2023-11-04 12:00 pm | Society for Immunotherapy of Cancer Meeting - Poster Number 124 |
| 2023-11-03 12:00 pm | Society for Immunotherapy of Cancer Meeting - Poster Number 105 |
| 2023-11-03 12:00 pm | Society for Immunotherapy of Cancer Meeting - Poster Number 117 |
| 2023-11-03 12:00 pm | Society for Immunotherapy of Cancer Meeting - Poster Number 97 |
| 2023-11-03 12:00 pm | Society for Immunotherapy of Cancer Meeting - Poster Number 75 |
| 2023-09-13 10:10 am | Morgan Stanley Global Healthcare Conference |
| 2023-08-17 06:00 pm | UBS Genomics 2.0 and MedTech Innovations Summit |
| 2023-08-09 09:00 am | Canaccord Growth Conference |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 42,4 | 54,9 54,7 0.37% | 74,9 74,1 0.99% | 96,6 96,3 0.37% | 116 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -34,6 -29,0 -19.23% | -59,4 -55,6 -6.82% | -49,6 -50,6 1.9% | -26,5 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -39,3 -33,0 -18.99% | -66,1 -62,9 -5.04% | -57,7 -60,2 4.14% | -36,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -43,1 -36,4 -18.5% | -70,5 -67,6 -4.31% | -63,3 -65,4 3.26% | -40,1 |
|
Net income Million USD | Released Forecast Spread | -16,7 | -44,4 -37,3 -18.95% | -70,6 -67,8 -4.2% | -63,3 -66,1 4.21% | -41,4 |
|
EPS USD | Released Forecast Spread | -9,18 | -1,65 -2,41 31.44% | -1,87 -1,81 -3.09% | -1,43 -1,48 3.08% | -0,84 |
| Announcement Date | 26/03/21 | 14/03/22 | 06/03/23 | 04/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 16,2 16,1 0.67% | 16,9 14,9 13.13% | 17,9 16,9 5.73% | 18,9 17,7 6.76% | 21,2 20,5 3.72% | 21,4 20,3 5.36% | 23,5 22,4 4.82% | 25,2 24,5 2.75% | 26,5 26,1 1.44% | 24,3 | 27,5 | 30,2 | 33,8 | 30,0 |
|
EBITDA Million USD | Released Forecast Spread | -15,4 -10,3 -50.3% | -14,0 -14,5 3.04% | -14,7 -12,3 -19.44% | -14,8 -13,0 -14.14% | -15,8 -13,2 -20.24% | -15,5 -14,9 -3.47% | -17,4 -13,4 -30.21% | -9,18 -11,5 19.86% | -7,57 -9,66 21.71% | -10,8 | -7,33 | -5,30 | -3,60 | -4,10 |
|
EBIT Million USD | Released Forecast Spread | -16,8 -10,8 -55.85% | -15,6 -13,2 -17.54% | -16,3 -12,6 -29.94% | -16,7 -15,8 -5.49% | -17,6 -15,4 -14.44% | -17,4 -17,3 -0.85% | -19,2 -16,4 -17.33% | -11,6 -15,0 22.93% | -9,44 -12,2 22.73% | -13,1 | -10,5 | -7,63 | -5,46 | -8,25 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -17,8 -11,0 -61.73% | -16,4 -14,2 -15.6% | -17,4 -12,7 -36.56% | -17,9 -16,4 -8.62% | -18,9 -15,9 -18.69% | -18,8 -18,4 -1.94% | -20,8 -17,7 -17.66% | -12,9 -16,5 21.68% | -10,8 -13,2 18.23% | -14,1 | -11,5 | -8,45 | -6,27 | -9,63 |
|
Net income Million USD | Released Forecast Spread | -17,7 -11,0 -60.66% | -16,4 -14,2 -15.76% | -17,5 -13,4 -30.32% | -17,9 -16,5 -8.03% | -18,9 -16,0 -17.99% | -18,8 -18,7 -0.45% | -20,8 -17,8 -16.93% | -12,9 -16,5 21.55% | -10,8 -13,8 21.65% | -14,3 | -11,8 | -8,90 | -6,78 | -9,85 |
|
EPS USD | Released Forecast Spread | -0,47 -0,30 -58.43% | -0,44 -0,39 -13.55% | -0,47 -0,37 -26.34% | -0,47 -0,44 -6.82% | -0,50 -0,44 -13.31% | -0,49 -0,49 -0.75% | -0,51 -0,46 -10.99% | -0,26 -0,36 28.63% | -0,22 -0,28 21.02% | -0,29 | -0,24 | -0,18 | -0,14 | -0,19 |
| Announcement Date | 14/03/22 | 05/05/22 | 08/08/22 | 07/11/22 | 06/03/23 | 08/05/23 | 07/08/23 | 08/11/23 | 04/03/24 | - | - | - | - | - |
| 2024-04-26 | SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: Q1 2024 Earnings Release |
| 2024-04-26 | SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-29 01:00 am | PHILIPS NV: Q1 2024 Earnings Release |
| 2024-04-29 06:00 am | REVVITY, INC.: Q1 2024 Earnings Release |
| 2024-04-30 06:20 am | GE HEALTHCARE TECHNOLOGIES INC.: Q1 2024 Earnings Release |
| 2024-04-30 04:05 pm | TRANSMEDICS GROUP, INC.: Q1 2024 Earnings Release |
| 2024-05-01 | INMODE LTD.: Q1 2024 Earnings Release |
| 2024-05-02 07:00 am | BRUKER CORPORATION: Q1 2024 Earnings Release |
| 2024-05-02 04:01 pm | HOLOGIC, INC.: Q2 2024 Earnings Release |
| 2024-05-02 04:05 pm | LEMAITRE VASCULAR, INC.: Q1 2024 Earnings Release |
Past sector events for Akoya Biosciences, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- AKYA Stock
- Calendar Akoya Biosciences, Inc.
